Ribavirin Completed Phase 2 Trials for Hepatitis C Viral Infection / Thalassaemic disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00502788Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)